-
3981por Thomas, Clare L, Man, Mei-See, O’Cathain, Alicia, Hollinghurst, Sandra, Large, Shirley, Edwards, Louisa, Nicholl, Jon, Montgomery, Alan A, Salisbury, Chris“…The study will also analyse health economic information. In doing so, the study hopes to address some of the limitations of previous research by demonstrating the effectiveness and cost-effectiveness of a real world telehealth intervention. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3982por Proskorovsky, Irina, Lewis, Philip, Williams, Cathy D, Jordan, Karin, Kyriakou, Charalampia, Ishak, Jack, Davies, Faith E“…BACKGROUND: In oncology, health-related quality of life (HRQoL) data are often collected using disease-specific patient questionnaires while generic, patient-level utility data required for health economic modeling are often not collected. METHODS: We developed a mapping algorithm for multiple myeloma that relates HRQoL scores from the European Organization for Research and Treatment of Cancer (EORTC) questionnaires QLQ-C30 and QLQ-MY20 to a utility value from the European QoL-5 Dimensions (EQ-5D) questionnaire. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3983Design of a school-based randomized trial to reduce smoking among 13 to 15-year olds, the X:IT studypor Andersen, Anette, Bast, Lotus Sofie, Ringgaard, Lene Winther, Wohllebe, Louise, Jensen, Poul Dengsøe, Svendsen, Maria, Dalum, Peter, Due, Pernille“…The study encompasses process- and effect-evaluations as well as health economic analyses. Ninety-four schools in 17 municipalities were randomly allocated to the intervention (51 schools) or control (43 schools) group. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3984por Waller, Helen, Craig, Tom, Landau, Sabine, Fornells-Ambrojo, Miriam, Hassanali, Nedah, Iredale, Catherine, Jolley, Suzanne, McCrone, Paul, Garety, Philippa“…Secondary outcome measures include mood, psychotic symptoms, quality of life and clinical distress. A health economic analysis comparing service use in each condition will also be performed. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3985por Moore, Carmel, Sambrook, Jennifer, Walker, Matthew, Tolkien, Zoe, Kaptoge, Stephen, Allen, David, Mehenny, Susan, Mant, Jonathan, Angelantonio, Emanuele Di, Thompson, Simon G, Ouwehand, Willem, Roberts, David J, Danesh, John“…Additional secondary endpoints include the number of ‘deferrals’ due to low haemoglobin (and other factors), iron status, cognitive function, physical activity, and donor attitudes. A comprehensive health economic analysis will be undertaken. DISCUSSION: The INTERVAL trial should yield novel information about the effect of inter-donation intervals on blood supply, acceptability, and donors’ physical and mental well-being. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3986por Mangham-Jefferies, Lindsay, Pitt, Catherine, Cousens, Simon, Mills, Anne, Schellenberg, Joanna“…The quality of the publications was assessed using the Consolidated Health Economic Evaluation Reporting Standards statement. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3987“…The second theme included the categories Patient-related aspects, Drug industry-related aspects, and Health economic aspects. The time-saving aspect, trust in evidence-based market-neutral guidelines and patient safety were described as key motivating factors for adherence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3988por Nichol, Alistair, French, Craig, Little, Lorraine, Presneill, Jeffrey, Cooper, D James, Haddad, Samir, Duranteau, Jacques, Huet, Olivier, Skrifvars, Markus, Arabi, Yaseen, Bellomo, Rinaldo“…Secondary outcomes will include the rate of proximal deep venous thrombosis detected by compression Doppler ultrasound, six-month mortality, the proportion of patients with composite vascular events (deep venous thrombosis, pulmonary embolism, myocardial infarction, cardiac arrest and cerebrovascular events) at six months and quality of life with health economic evaluations. DISCUSSION: When completed, the trial aims to provide evidence on the efficacy and safety of erythropoietin in traumatic brain injury patients, and to provide clear guidance for clinicians in their management of this devastating condition. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3989por van der Putten, Ingeborg M, Evers, Silvia MAA, Deogaonkar, Rohan, Jit, Mark, Hutubessy, Raymond CW“…BACKGROUND: Current health economic evaluation guidelines mainly concentrate on immediate health gains and cost savings for the individual involved in the intervention. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3990por Rodgers, Helen, Shaw, Lisa, Cant, Robin, Drummond, Avril, Ford, Gary A, Forster, Anne, Hills, Katie, Howel, Denise, Laverty, Anne-Marie, McKevitt, Christopher, McMeekin, Peter, Price, Christopher“…METHODS/DESIGN: This study is a multicentre randomised controlled trial with health economic and process evaluations. It is set within NHS stroke services which provide ESD. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3991por Leong, Trevor, Smithers, B Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Simes, John, Zalcberg, John, Haustermans, Karin, Lordick, Florian, Schuhmacher, Christoph, Swallow, Carol, Darling, Gail, Wong, Rebecca“…The trial includes quality of life and biological substudies, as well as a health economic evaluation. In addition, the trial incorporates a rigorous quality assurance program that includes real time central review of radiotherapy plans and central review of surgical technique. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3992por Dodd, Jodie M, Ahmed, Sharmina, Karnon, Jonathan, Umberger, Wendy, Deussen, Andrea R, Tran, Thach, Grivell, Rosalie M, Crowther, Caroline A, Turnbull, Deborah, McPhee, Andrew J, Wittert, Gary, Owens, Julie A, Robinson, Jeffrey S“…BACKGROUND: Overweight and obesity during pregnancy is common, although robust evidence about the economic implications of providing an antenatal dietary and lifestyle intervention for women who are overweight or obese is lacking. We conducted a health economic evaluation in parallel with the LIMIT randomised trial. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3993por Freire, Elizabeth, Williams, Christopher, Messow, Claudia-Martina, Cooper, Mick, Elliott, Robert, McConnachie, Alex, Walker, Andrew, Heard, Deborah, Morrison, Jill“…The evidence from this study suggests that short-term Person-Centred Counselling and Low-Intensity Cognitive Behaviour Therapy are potentially effective and their effectiveness should be evaluated in a larger randomised controlled study which includes a health economic evaluation. TRIAL REGISTRATION: Current Controlled Trials ISRCTN60972025.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3994por Gutzwiller, Florian S., Pfeil, Alena M., Ademi, Zanfina, Blank, Patricia R., Braunhofer, Peter G., Szucs, Thomas D., Schwenkglenks, Matthias“…OBJECTIVE: The aim of this study was to determine the health economic impact of PA21-based strategies compared with SC-based strategies, from the perspective of the Scottish National Health Service (NHS). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3995por Halloran, Christopher M., Platt, Kellie, Gerard, Abbie, Polydoros, Fotis, O’Reilly, Derek A., Gomez, Dhanwant, Smith, Andrew, Neoptolemos, John P., Soonwalla, Zahir, Taylor, Mark, Blazeby, Jane M., Ghaneh, Paula“…Secondary outcome measures are: entry into adjuvant therapy, mortality, surgical complications, non-surgical complications, hospital stay, cancer-specific quality of life and health economic assessments. Enrolled patients will undergo pancreatic resection and be randomized immediately prior to pancreatic reconstruction. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3996por Burchell, Ann N., Allen, Vanessa G., Grewal, Ramandip, MacPherson, Paul A., Rachlis, Anita, Walmsley, Sharon, Mishra, Sharmistha, Gardner, Sandra L., Raboud, Janet, Cooper, Curtis, Gough, Kevin, Rourke, Sean B., Rousseau, Rodney, Salit, Irving, Tan, Darrell H. S.“…Process evaluation plans include audit and feedback of compliance of the participating centers to identify potential barriers to the introduction of this type of practice into routine care. Health economic components include evaluation of the impact and cost-effectiveness of the intervention. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3997por Kipp, Aaron M, Blevins, Meridith, Haley, Connie A, Mwinga, Kasonde, Habimana, Phanuel, Shepherd, Bryan E, Aliyu, Muktar H, Ketsela, Tigest, Vermund, Sten H“…Progress has been variable across African countries. We examined health, economic and social factors potentially associated with reductions in under-five mortality (U5M) from 2000 to 2013. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3998por Kemmeren, L. L., van Schaik, D. J. F., Riper, H., Kleiboer, A. M., Bosmans, J. E., Smit, J. H.“…Also, little is known about the clinical and health-economic benefits of blended treatment, where online interventions are integrated with face-to-face treatment of depression in one treatment protocol. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3999por Stingl, Julia Carolin, Kaumanns, Katharina Luise, Claus, Katrin, Lehmann, Marie-Louise, Kastenmüller, Kathrin, Bleckwenn, Markus, Hartmann, Gunther, Steffens, Michael, Wirtz, Dorothee, Leuchs, Ann-Kristin, Benda, Norbert, Meier, Florian, Schöffski, Oliver, Holdenrieder, Stefan, Coch, Christoph, Weckbecker, Klaus“…DISCUSSION: Despite extensive evidence of risk factors for adverse drug reactions, there are few prospective trial data about an individualized risk assessment including pharmacogenetic information to increase patient safety. By conducting a health economic analysis, we will evaluate if the application of an individualized drug therapy in daily routine is cost-effective. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4000por Turner-Stokes, Lynne, Ashford, Stephen, Jacinto, Jorge, Maisonobe, Pascal, Balcaitiene, Jovita, Fheodoroff, Klemens“…Concomitant therapy inputs, patient satisfaction with engagement in goal setting, health economic end points and health-related quality of life data will also be captured. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto